Analyst Price Targets — CARL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 6, 2026 9:10 am | Richard Newitter | Truist Financial | $20.00 | $13.56 | StreetInsider | Carlsmed Inc (CARL) PT Raised to $20 at Truist Securities |
| July 1, 2026 9:56 am | David Saxon | Needham | $17.00 | $10.38 | TheFly | Carlsmed initiated with a Buy at Needham |
| April 15, 2026 12:25 pm | — | Truist Financial | $18.00 | $10.80 | TheFly | Carlsmed price target lowered to $18 from $20 at Truist |
| January 9, 2026 10:49 am | — | Goldman Sachs | $20.00 | $12.87 | TheFly | Carlsmed price target raised to $20 from $19 at Goldman Sachs |
| December 15, 2025 10:54 am | Ryan Zimmerman | BTIG | $24.00 | $12.95 | StreetInsider | BTIG Reiterates Buy Rating on Carlsmed Inc (CARL) |
| August 18, 2025 8:49 am | Matt O'Brien | Piper Sandler | $18.00 | $13.58 | TheFly | Carlsmed initiated with an Overweight at Piper Sandler |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CARL

Carlsmed NASDAQ: CARL outlined its strategy for expanding its personalized spine-surgery platform, citing clinical data, reimbursement changes and a planned cervical product launch as potential drivers of growth during a Bank of America small- and mid-cap virtual event.

Carlsmed, Inc. (CARL) Presents at Bank of America SMID Cap Virtual Conference Transcript

Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript

Carlsmed NASDAQ: CARL reported second-quarter 2026 revenue of $18.9 million, up 57% from $12.1 million a year earlier, as growth in its aprevo lumbar platform and contributions from its newer cervical offering lifted procedure volumes.

Carlsmed, Inc. (CARL) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $1.47 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CARL.
U.S. House Trading
No House trades found for CARL.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
